Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction

Conclusions
Antiplatelet therapy can be safely used between 24 and 48 hours when HI occurs after IVT, and such therapy is associated with reduced risk of END and improved neurological outcome in patients who had an AIS.

Source: Journal of Neurology, Neurosurgery and Psychiatry - July 14, 2022 Category: Neurosurgery Authors: Zhong, W., Yan, S., Chen, Z., Luo, Z., Chen, Y., Zhang, X., Wu, C., Tang, W., Zhang, X., Wang, Y., Gu, Q., Xu, D., Chen, H., Lou, M., on behalf of the CASE-II Study Group Tags: Cerebrovascular disease Source Type: research